Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PROSPECTIVE, MULTI-CENTER, OPEN-LABEL, SUPERIORITY, RANDOMIZED, CONTROLLED REGISTRATION TRIAL OF THE RAPAMYCIN NEUROVASCULAR BALLOON CATHETER FOR THE TREATMENT OF SYMPTOMATIC CEREBRAL ATHEROSCLEROTIC STENOSIS

NCT06683118 is registered in ClinicalTrials.gov with MicroPort NeuroTech Co., Ltd. as lead sponsor.

NCT NCT06683118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06683118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PROSPECTIVE, MULTI-CENTER, OPEN-LABEL, SUPERIORITY, RANDOMIZED, CONTROLLED REGISTRATION TRIAL OF THE RAPAMYCIN NEUROVASCULAR BALLOON CATHETER FOR THE TREATMENT OF SYMPTOMATIC CEREBRAL ATHEROSCLEROTIC STENOSIS
Lead sponsor
MicroPort NeuroTech Co., Ltd.
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
May 27, 2024
Completion date
July 27, 2026
Enrollment
212 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral atherosclerotic stenosis